NASDAQ
Financial data for PCRX
3.85% YoY
337.30% YoY
336.26% YoY
Annual Income Statement for PCRX
| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $701M | $675M | $667M | $542M | $430M |
| Cost of Revenue | $170M | $185M | $199M | $140M | $117M |
| Gross Profit | $531M | $490M | $468M | $401M | $312M |
| Operating Expenses | $604M | $403M | $408M | $311M | $266M |
| Operating Income | -$73M | $88M | $60M | $90M | $46M |
| Net Income | -$100M | $42M | $16M | $42M | $146M |
| EPS | $-2.15 | $0.91 | $0.35 | $0.95 | $3.41 |
| EBITDA | $29M | $155M | $140M | $114M | $64M |
No price data available for this timeframe.